{"id":1418552,"title":"DSEN Abstract: Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-05-02","captureTimestamp":"2026-05-02T14:55:02.117000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53213.html","snippet":"DSEN Abstract Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure Despite low rates of sofosbuvir failure in the pivotal clinical trials (2 - 4%), this real-world trial shows a higher failure rate of 9.5%. This study also found that patients…","rawSnapshotUrl":"/api/snapshots/raw/1418552","browseUrl":"https://replay.healtharchive.ca/job-8/20260502145502/https://cihr-irsc.gc.ca/e/53213.html#ha_snapshot=1418552","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}